| scholarly article | Q13442814 |
| P8978 | DBLP publication ID | journals/jcisd/TiikkainenF12 |
| P356 | DOI | 10.1021/CI2003126 |
| P953 | full work available at URL | https://pubs.acs.org/doi/pdf/10.1021/ci2003126 |
| P698 | PubMed publication ID | 22145975 |
| P2093 | author name string | Lutz Franke | |
| Pekka Tiikkainen | |||
| P2860 | cites work | IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels | Q24259024 |
| ChemProt: a disease chemical biology database | Q24608769 | ||
| DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 | ||
| The Transporter Classification Database: recent advances | Q24655401 | ||
| BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities | Q24675698 | ||
| Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds | Q27701890 | ||
| How many drug targets are there? | Q28276660 | ||
| ChEMBL: a large-scale bioactivity database for drug discovery | Q28315179 | ||
| An overview of the PubChem BioAssay resource | Q28749237 | ||
| A quality alert and call for improved curation of public chemistry databases | Q28842731 | ||
| Global mapping of pharmacological space | Q29615876 | ||
| Relating protein pharmacology by ligand chemistry | Q29617492 | ||
| Minimum information about a bioactive entity (MIABE). | Q34212022 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fact database | Q1393704 |
| P304 | page(s) | 319-326 | |
| P577 | publication date | 2011-12-06 | |
| P1433 | published in | Journal of Chemical Information and Modeling | Q3007982 |
| 2011 Noordwijkerhout Cheminformatics | Q130391385 | ||
| P1476 | title | Analysis of commercial and public bioactivity databases | |
| Analysis of Commercial and Public Bioactivity Databases | |||
| P478 | volume | 52 |
| Q59771352 | A new semi-automated workflow for chemical data retrieval and quality checking for modeling applications |
| Q47348618 | Cheminformatics in the Service of GPCR Drug Discovery |
| Q26772939 | Chemoinformatics: Achievements and Challenges, a Personal View |
| Q43112468 | Comparative analyses of structural features and scaffold diversity for purchasable compound libraries |
| Q108527458 | Computational Approaches for Target Inference |
| Q28659783 | Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software |
| Q37544812 | Construction of antimicrobial peptide-drug combination networks from scientific literature based on a semi-automated curation workflow. |
| Q42966532 | Deep-learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data. |
| Q96644023 | Enhancing chemogenomics with predictive pharmacology |
| Q35026552 | Estimating error rates in bioactivity databases |
| Q47893147 | Evidence-Based Precision Oncology with the Cancer Targetome. |
| Q35532344 | Extending in silico mechanism-of-action analysis by annotating targets with pathways: application to cellular cytotoxicity readouts |
| Q38915525 | Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts |
| Q46972686 | FAst MEtabolizer (FAME): A rapid and accurate predictor of sites of metabolism in multiple species by endogenous enzymes |
| Q34670175 | Fighting Obesity with a Sugar-Based Library: Discovery of Novel MCH-1R Antagonists by a New Computational–VAST Approach for Exploration of GPCR Binding Sites |
| Q38155471 | GPCR & company: databases and servers for GPCRs and interacting partners. |
| Q51053334 | Generalized workflow for generating highly predictive in silico off-target activity models |
| Q56888960 | High-Throughput Screening Assay Datasets from the PubChem Database |
| Q30653633 | In silico target predictions: defining a benchmarking data set and comparison of performance of the multiclass Naïve Bayes and Parzen-Rosenblatt window |
| Q88171302 | Industrial applications of in silico ADMET |
| Q27943500 | Many InChIs and quite some feat |
| Q38453607 | PharmaTrek: A Semantic Web Explorer for Open Innovation in Multitarget Drug Discovery |
| Q35103940 | Predictive in silico off-target profiling in drug discovery |
| Q28222668 | QSAR modeling: where have you been? Where are you going to? |
| Q36092094 | Quality Issues with Public Domain Chemogenomics Data. |
| Q35681868 | Role of Open Source Tools and Resources in Virtual Screening for Drug Discovery |
| Q36946451 | The CARLSBAD database: a confederated database of chemical bioactivities |
| Q34285419 | The experimental uncertainty of heterogeneous public K(i) data. |
| Q42278847 | VB-MK-LMF: fusion of drugs, targets and interactions using variational Bayesian multiple kernel logistic matrix factorization. |
| Q30723310 | Web search and data mining of natural products and their bioactivities in PubChem |
Search more.